SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018 - 2020)

SELLAS Life Sciences (SLS) reported Preferred Dividend Payments of $78000.0 for Q1 2020, down 82.23% year-over-year from $439000.0 in Q2 2019, and up 132.1% quarter-over-quarter from -$243000.0 in Q4 2019.

SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018 - 2020) Analysis & Trends

SELLAS Life Sciences (SLS) has 3 years of Preferred Dividend Payments data on file, last reported at $78000.0 in Q1 2020.

  • Preferred Dividend Payments for Q1 2020 came in at $78000.0, down 82.23% year-over-year; the trailing twelve-month figure through Dec 2020 was $78000.0 (down 99.07% YoY), and the FY2020 annual result was $78000.0, down 99.07% from the prior year.
  • Preferred Dividend Payments rose to $78000.0 in Q1 2020 per SLS's latest filing, from -$243000.0 in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $7.3 million in Q3 2019 and troughed at -$4.4 million in Q4 2018.
  • A 3-year average of $814625.0 and a median of $465000.0 in 2018 frame the typical range for Preferred Dividend Payments.
  • The sharpest annual moves came in 2019 and 2020: Preferred Dividend Payments surged 1380.24% in 2019, then slumped 82.23% in 2020.
  • A 3-year view of Preferred Dividend Payments shows it stood at -$4.4 million in 2018, then soared by 94.52% to -$243000.0 in 2019, then soared by 132.1% to $78000.0 in 2020.
  • Business Quant data shows SLS's Preferred Dividend Payments at $78000.0 in Q1 2020, -$243000.0 in Q4 2019, and $7.3 million in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 SELLAS Life Sciences 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 78,000.00
Dec 31, 2019 -243,000.00
Sep 30, 2019 7.27 Mn
Jun 30, 2019 952,000.00
Mar 31, 2019 439,000.00
Dec 31, 2018 -4.44 Mn
Sep 30, 2018 491,000.00
Mar 31, 2018 1.97 Mn